nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRA—prostate cancer	0.562	1	CbGaD
Isotretinoin—RARB—prostate gland—prostate cancer	0.00367	0.123	CbGeAlD
Isotretinoin—RXRG—prostate gland—prostate cancer	0.00359	0.12	CbGeAlD
Isotretinoin—RARG—prostate gland—prostate cancer	0.003	0.1	CbGeAlD
Isotretinoin—RARA—prostate gland—prostate cancer	0.00282	0.0942	CbGeAlD
Isotretinoin—RXRA—renal system—prostate cancer	0.00279	0.0932	CbGeAlD
Isotretinoin—RARG—urethra—prostate cancer	0.00201	0.0671	CbGeAlD
Isotretinoin—RARA—renal system—prostate cancer	0.00192	0.0642	CbGeAlD
Isotretinoin—RXRG—testis—prostate cancer	0.00158	0.0529	CbGeAlD
Isotretinoin—RXRB—testis—prostate cancer	0.00149	0.0497	CbGeAlD
Isotretinoin—RARA—bone marrow—prostate cancer	0.00145	0.0486	CbGeAlD
Isotretinoin—Vitamin A—ALDH1A2—prostate cancer	0.00135	0.209	CrCbGaD
Isotretinoin—RARG—testis—prostate cancer	0.00132	0.0441	CbGeAlD
Isotretinoin—Tretinoin—ALDH1A2—prostate cancer	0.0013	0.201	CrCbGaD
Isotretinoin—RARA—testis—prostate cancer	0.00124	0.0415	CbGeAlD
Isotretinoin—RARB—lymph node—prostate cancer	0.00117	0.0392	CbGeAlD
Isotretinoin—Acitretin—RXRA—prostate cancer	0.000992	0.154	CrCbGaD
Isotretinoin—RARG—lymph node—prostate cancer	0.000957	0.032	CbGeAlD
Isotretinoin—Alitretinoin—RXRA—prostate cancer	0.000951	0.147	CrCbGaD
Isotretinoin—RARA—lymph node—prostate cancer	0.0009	0.0301	CbGeAlD
Isotretinoin—Tretinoin—RXRA—prostate cancer	0.00067	0.104	CrCbGaD
Isotretinoin—Tretinoin—CYP2C18—prostate cancer	0.000343	0.0531	CrCbGaD
Isotretinoin—Tretinoin—CYP3A5—prostate cancer	0.000226	0.035	CrCbGaD
Isotretinoin—Tretinoin—CYP2A6—prostate cancer	0.000219	0.0339	CrCbGaD
Isotretinoin—Vitamin A—CYP1A1—prostate cancer	0.000159	0.0246	CrCbGaD
Isotretinoin—Tretinoin—CYP1A1—prostate cancer	0.000153	0.0237	CrCbGaD
Isotretinoin—Tretinoin—CYP3A4—prostate cancer	9.78e-05	0.0151	CrCbGaD
Isotretinoin—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.74e-05	0.000118	CcSEcCtD
Isotretinoin—Headache—Mitoxantrone—prostate cancer	2.73e-05	0.000117	CcSEcCtD
Isotretinoin—Hypotension—Capecitabine—prostate cancer	2.73e-05	0.000117	CcSEcCtD
Isotretinoin—Insomnia—Docetaxel—prostate cancer	2.72e-05	0.000117	CcSEcCtD
Isotretinoin—Myalgia—Prednisone—prostate cancer	2.71e-05	0.000117	CcSEcCtD
Isotretinoin—Arthralgia—Prednisone—prostate cancer	2.71e-05	0.000117	CcSEcCtD
Isotretinoin—Paraesthesia—Docetaxel—prostate cancer	2.71e-05	0.000116	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—prostate cancer	2.7e-05	0.000116	CcSEcCtD
Isotretinoin—Anxiety—Prednisone—prostate cancer	2.7e-05	0.000116	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.69e-05	0.000116	CcSEcCtD
Isotretinoin—Dyspnoea—Docetaxel—prostate cancer	2.69e-05	0.000116	CcSEcCtD
Isotretinoin—Somnolence—Docetaxel—prostate cancer	2.68e-05	0.000115	CcSEcCtD
Isotretinoin—Discomfort—Prednisone—prostate cancer	2.68e-05	0.000115	CcSEcCtD
Isotretinoin—Eye disorder—Epirubicin—prostate cancer	2.67e-05	0.000115	CcSEcCtD
Isotretinoin—Hypersensitivity—Etoposide—prostate cancer	2.67e-05	0.000115	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—prostate cancer	2.67e-05	0.000115	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—prostate cancer	2.66e-05	0.000114	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.66e-05	0.000114	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—prostate cancer	2.65e-05	0.000114	CcSEcCtD
Isotretinoin—Dyspepsia—Docetaxel—prostate cancer	2.65e-05	0.000114	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—prostate cancer	2.65e-05	0.000114	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—prostate cancer	2.65e-05	0.000114	CcSEcCtD
Isotretinoin—Insomnia—Capecitabine—prostate cancer	2.64e-05	0.000113	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—prostate cancer	2.63e-05	0.000113	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—prostate cancer	2.63e-05	0.000113	CcSEcCtD
Isotretinoin—Paraesthesia—Capecitabine—prostate cancer	2.62e-05	0.000113	CcSEcCtD
Isotretinoin—Decreased appetite—Docetaxel—prostate cancer	2.62e-05	0.000113	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—prostate cancer	2.61e-05	0.000112	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—prostate cancer	2.61e-05	0.000112	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Docetaxel—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Asthenia—Etoposide—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Dyspnoea—Capecitabine—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Oedema—Prednisone—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Anaphylactic shock—Prednisone—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Fatigue—Docetaxel—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—prostate cancer	2.6e-05	0.000112	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—prostate cancer	2.59e-05	0.000112	CcSEcCtD
Isotretinoin—Nausea—Mitoxantrone—prostate cancer	2.59e-05	0.000111	CcSEcCtD
Isotretinoin—Infection—Prednisone—prostate cancer	2.58e-05	0.000111	CcSEcCtD
Isotretinoin—Constipation—Docetaxel—prostate cancer	2.58e-05	0.000111	CcSEcCtD
Isotretinoin—Pain—Docetaxel—prostate cancer	2.58e-05	0.000111	CcSEcCtD
Isotretinoin—Dyspepsia—Capecitabine—prostate cancer	2.57e-05	0.00011	CcSEcCtD
Isotretinoin—Chills—Epirubicin—prostate cancer	2.57e-05	0.00011	CcSEcCtD
Isotretinoin—Pruritus—Etoposide—prostate cancer	2.56e-05	0.00011	CcSEcCtD
Isotretinoin—Shock—Prednisone—prostate cancer	2.56e-05	0.00011	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—prostate cancer	2.56e-05	0.00011	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—prostate cancer	2.55e-05	0.00011	CcSEcCtD
Isotretinoin—Nervous system disorder—Prednisone—prostate cancer	2.55e-05	0.00011	CcSEcCtD
Isotretinoin—Tachycardia—Prednisone—prostate cancer	2.54e-05	0.000109	CcSEcCtD
Isotretinoin—Decreased appetite—Capecitabine—prostate cancer	2.54e-05	0.000109	CcSEcCtD
Isotretinoin—Alopecia—Epirubicin—prostate cancer	2.53e-05	0.000109	CcSEcCtD
Isotretinoin—Skin disorder—Prednisone—prostate cancer	2.52e-05	0.000109	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Capecitabine—prostate cancer	2.52e-05	0.000108	CcSEcCtD
Isotretinoin—Fatigue—Capecitabine—prostate cancer	2.51e-05	0.000108	CcSEcCtD
Isotretinoin—Hyperhidrosis—Prednisone—prostate cancer	2.51e-05	0.000108	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—prostate cancer	2.51e-05	0.000108	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—prostate cancer	2.5e-05	0.000108	CcSEcCtD
Isotretinoin—Pain—Capecitabine—prostate cancer	2.49e-05	0.000107	CcSEcCtD
Isotretinoin—Constipation—Capecitabine—prostate cancer	2.49e-05	0.000107	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—prostate cancer	2.49e-05	0.000107	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—prostate cancer	2.49e-05	0.000107	CcSEcCtD
Isotretinoin—Feeling abnormal—Docetaxel—prostate cancer	2.48e-05	0.000107	CcSEcCtD
Isotretinoin—Diarrhoea—Etoposide—prostate cancer	2.48e-05	0.000107	CcSEcCtD
Isotretinoin—Anorexia—Prednisone—prostate cancer	2.48e-05	0.000106	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—prostate cancer	2.47e-05	0.000106	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—prostate cancer	2.47e-05	0.000106	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Docetaxel—prostate cancer	2.46e-05	0.000106	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—prostate cancer	2.46e-05	0.000106	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—prostate cancer	2.45e-05	0.000106	CcSEcCtD
Isotretinoin—Tension—Epirubicin—prostate cancer	2.44e-05	0.000105	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—prostate cancer	2.42e-05	0.000104	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—prostate cancer	2.41e-05	0.000104	CcSEcCtD
Isotretinoin—Feeling abnormal—Capecitabine—prostate cancer	2.4e-05	0.000103	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—prostate cancer	2.4e-05	0.000103	CcSEcCtD
Isotretinoin—Dizziness—Etoposide—prostate cancer	2.4e-05	0.000103	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Capecitabine—prostate cancer	2.39e-05	0.000103	CcSEcCtD
Isotretinoin—Abdominal pain—Docetaxel—prostate cancer	2.38e-05	0.000102	CcSEcCtD
Isotretinoin—Body temperature increased—Docetaxel—prostate cancer	2.38e-05	0.000102	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—prostate cancer	2.37e-05	0.000102	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.37e-05	0.000102	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—prostate cancer	2.36e-05	0.000102	CcSEcCtD
Isotretinoin—Insomnia—Prednisone—prostate cancer	2.35e-05	0.000101	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—prostate cancer	2.35e-05	0.000101	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—prostate cancer	2.34e-05	0.000101	CcSEcCtD
Isotretinoin—Paraesthesia—Prednisone—prostate cancer	2.33e-05	0.0001	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—prostate cancer	2.32e-05	9.97e-05	CcSEcCtD
Isotretinoin—Urticaria—Capecitabine—prostate cancer	2.32e-05	9.96e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—prostate cancer	2.31e-05	9.93e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Capecitabine—prostate cancer	2.31e-05	9.92e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Capecitabine—prostate cancer	2.31e-05	9.92e-05	CcSEcCtD
Isotretinoin—Vomiting—Etoposide—prostate cancer	2.3e-05	9.91e-05	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—prostate cancer	2.3e-05	9.91e-05	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—prostate cancer	2.3e-05	9.91e-05	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—prostate cancer	2.3e-05	9.9e-05	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—prostate cancer	2.29e-05	9.84e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Prednisone—prostate cancer	2.29e-05	9.83e-05	CcSEcCtD
Isotretinoin—Rash—Etoposide—prostate cancer	2.29e-05	9.83e-05	CcSEcCtD
Isotretinoin—Dermatitis—Etoposide—prostate cancer	2.28e-05	9.82e-05	CcSEcCtD
Isotretinoin—Headache—Etoposide—prostate cancer	2.27e-05	9.77e-05	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—prostate cancer	2.27e-05	9.76e-05	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—prostate cancer	2.26e-05	9.72e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Prednisone—prostate cancer	2.26e-05	9.71e-05	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—prostate cancer	2.25e-05	9.66e-05	CcSEcCtD
Isotretinoin—Fatigue—Prednisone—prostate cancer	2.24e-05	9.63e-05	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—prostate cancer	2.24e-05	9.62e-05	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—prostate cancer	2.23e-05	9.6e-05	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—prostate cancer	2.23e-05	9.58e-05	CcSEcCtD
Isotretinoin—Constipation—Prednisone—prostate cancer	2.22e-05	9.55e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Docetaxel—prostate cancer	2.22e-05	9.54e-05	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—prostate cancer	2.2e-05	9.46e-05	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—prostate cancer	2.19e-05	9.41e-05	CcSEcCtD
Isotretinoin—Cough—Epirubicin—prostate cancer	2.17e-05	9.34e-05	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—prostate cancer	2.17e-05	9.34e-05	CcSEcCtD
Isotretinoin—Asthenia—Docetaxel—prostate cancer	2.16e-05	9.3e-05	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—prostate cancer	2.16e-05	9.28e-05	CcSEcCtD
Isotretinoin—Nausea—Etoposide—prostate cancer	2.15e-05	9.26e-05	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—prostate cancer	2.15e-05	9.24e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Capecitabine—prostate cancer	2.15e-05	9.24e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Prednisone—prostate cancer	2.14e-05	9.21e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—prostate cancer	2.14e-05	9.19e-05	CcSEcCtD
Isotretinoin—Pruritus—Docetaxel—prostate cancer	2.13e-05	9.17e-05	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—prostate cancer	2.13e-05	9.16e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Prednisone—prostate cancer	2.12e-05	9.14e-05	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—prostate cancer	2.12e-05	9.12e-05	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—prostate cancer	2.12e-05	9.12e-05	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—prostate cancer	2.12e-05	9.12e-05	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—prostate cancer	2.12e-05	9.1e-05	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—prostate cancer	2.11e-05	9.08e-05	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.11e-05	9.05e-05	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—prostate cancer	2.09e-05	9.01e-05	CcSEcCtD
Isotretinoin—Asthenia—Capecitabine—prostate cancer	2.09e-05	9e-05	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—prostate cancer	2.08e-05	8.93e-05	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—prostate cancer	2.07e-05	8.91e-05	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—prostate cancer	2.07e-05	8.88e-05	CcSEcCtD
Isotretinoin—Urticaria—Prednisone—prostate cancer	2.06e-05	8.88e-05	CcSEcCtD
Isotretinoin—Pruritus—Capecitabine—prostate cancer	2.06e-05	8.87e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Docetaxel—prostate cancer	2.06e-05	8.86e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Prednisone—prostate cancer	2.05e-05	8.83e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Prednisone—prostate cancer	2.05e-05	8.83e-05	CcSEcCtD
Isotretinoin—Confusional state—Epirubicin—prostate cancer	2.05e-05	8.81e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NCOA1—prostate cancer	2.04e-05	0.00012	CbGpPWpGaD
Isotretinoin—Palpitations—Doxorubicin—prostate cancer	2.04e-05	8.75e-05	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—prostate cancer	2.03e-05	8.74e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—prostate cancer	2.03e-05	8.74e-05	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—prostate cancer	2.02e-05	8.71e-05	CcSEcCtD
Isotretinoin—Infection—Epirubicin—prostate cancer	2.02e-05	8.68e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	2.02e-05	0.000119	CbGpPWpGaD
Isotretinoin—Cough—Doxorubicin—prostate cancer	2.01e-05	8.64e-05	CcSEcCtD
Isotretinoin—Shock—Epirubicin—prostate cancer	2e-05	8.6e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—NCOA1—prostate cancer	2e-05	0.000118	CbGpPWpGaD
Isotretinoin—Convulsion—Doxorubicin—prostate cancer	2e-05	8.58e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Capecitabine—prostate cancer	2e-05	8.58e-05	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—prostate cancer	1.99e-05	8.57e-05	CcSEcCtD
Isotretinoin—Dizziness—Docetaxel—prostate cancer	1.99e-05	8.57e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—prostate cancer	1.99e-05	8.56e-05	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—prostate cancer	1.99e-05	8.55e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—AR—prostate cancer	1.99e-05	0.000117	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.98e-05	0.000117	CbGpPWpGaD
Isotretinoin—Tachycardia—Epirubicin—prostate cancer	1.98e-05	8.53e-05	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—prostate cancer	1.97e-05	8.49e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.97e-05	0.000117	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PRKCQ—prostate cancer	1.97e-05	0.000116	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.97e-05	0.000116	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Epirubicin—prostate cancer	1.96e-05	8.45e-05	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—prostate cancer	1.96e-05	8.43e-05	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—prostate cancer	1.96e-05	8.43e-05	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—prostate cancer	1.96e-05	8.43e-05	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—prostate cancer	1.95e-05	8.41e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—AR—prostate cancer	1.95e-05	0.000115	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCOA1—prostate cancer	1.95e-05	0.000115	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.95e-05	8.38e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—SIRT1—prostate cancer	1.95e-05	0.000115	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TGFB1—prostate cancer	1.94e-05	0.000115	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—RXRA—prostate cancer	1.94e-05	0.000115	CbGpPWpGaD
Isotretinoin—Discomfort—Doxorubicin—prostate cancer	1.94e-05	8.33e-05	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—prostate cancer	1.94e-05	8.33e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—EIF3A—prostate cancer	1.93e-05	0.000114	CbGpPWpGaD
Isotretinoin—Dizziness—Capecitabine—prostate cancer	1.93e-05	8.29e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—TNFRSF21—prostate cancer	1.92e-05	0.000114	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—VDR—prostate cancer	1.92e-05	0.000113	CbGpPWpGaD
Isotretinoin—Dry mouth—Doxorubicin—prostate cancer	1.92e-05	8.25e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NCOA1—prostate cancer	1.92e-05	0.000113	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NCOA1—prostate cancer	1.92e-05	0.000113	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AR—prostate cancer	1.92e-05	0.000113	CbGpPWpGaD
Isotretinoin—Vomiting—Docetaxel—prostate cancer	1.92e-05	8.24e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Prednisone—prostate cancer	1.91e-05	8.23e-05	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.9e-05	0.000112	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—RXRA—prostate cancer	1.9e-05	0.000112	CbGpPWpGaD
Isotretinoin—Rash—Docetaxel—prostate cancer	1.9e-05	8.17e-05	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—prostate cancer	1.9e-05	8.17e-05	CcSEcCtD
Isotretinoin—Dermatitis—Docetaxel—prostate cancer	1.9e-05	8.16e-05	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—prostate cancer	1.9e-05	8.15e-05	CcSEcCtD
Isotretinoin—Headache—Docetaxel—prostate cancer	1.89e-05	8.12e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—prostate cancer	1.88e-05	8.09e-05	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—prostate cancer	1.88e-05	8.09e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.88e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—FGF10—prostate cancer	1.87e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTAP—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP7B1—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Isotretinoin—Infection—Doxorubicin—prostate cancer	1.87e-05	8.03e-05	CcSEcCtD
Isotretinoin—Asthenia—Prednisone—prostate cancer	1.86e-05	8.02e-05	CcSEcCtD
Isotretinoin—Vomiting—Capecitabine—prostate cancer	1.85e-05	7.98e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.85e-05	7.96e-05	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—prostate cancer	1.85e-05	7.95e-05	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—prostate cancer	1.84e-05	7.93e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—prostate cancer	1.84e-05	7.92e-05	CcSEcCtD
Isotretinoin—Rash—Capecitabine—prostate cancer	1.84e-05	7.91e-05	CcSEcCtD
Isotretinoin—Pruritus—Prednisone—prostate cancer	1.84e-05	7.9e-05	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—prostate cancer	1.84e-05	7.9e-05	CcSEcCtD
Isotretinoin—Dermatitis—Capecitabine—prostate cancer	1.84e-05	7.9e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—AR—prostate cancer	1.84e-05	0.000109	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AR—prostate cancer	1.84e-05	0.000109	CbGpPWpGaD
Isotretinoin—Tachycardia—Doxorubicin—prostate cancer	1.84e-05	7.89e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.83e-05	0.000108	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.83e-05	0.000108	CbGpPWpGaD
Isotretinoin—Headache—Capecitabine—prostate cancer	1.83e-05	7.86e-05	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—prostate cancer	1.83e-05	7.85e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—prostate cancer	1.82e-05	7.85e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—RXRA—prostate cancer	1.82e-05	0.000108	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—RXRA—prostate cancer	1.82e-05	0.000108	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SULT1E1—prostate cancer	1.82e-05	0.000108	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SRD5A1—prostate cancer	1.82e-05	0.000108	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Doxorubicin—prostate cancer	1.82e-05	7.82e-05	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—prostate cancer	1.81e-05	7.79e-05	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—prostate cancer	1.81e-05	7.77e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—VAV3—prostate cancer	1.81e-05	0.000107	CbGpPWpGaD
Isotretinoin—Anorexia—Doxorubicin—prostate cancer	1.79e-05	7.71e-05	CcSEcCtD
Isotretinoin—Nausea—Docetaxel—prostate cancer	1.79e-05	7.7e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—prostate cancer	1.79e-05	7.69e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—VDR—prostate cancer	1.79e-05	0.000106	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.78e-05	0.000105	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SIRT1—prostate cancer	1.78e-05	0.000105	CbGpPWpGaD
Isotretinoin—Diarrhoea—Prednisone—prostate cancer	1.78e-05	7.64e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.77e-05	0.000105	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—prostate cancer	1.77e-05	0.000104	CbGpPWpGaD
Isotretinoin—Decreased appetite—Epirubicin—prostate cancer	1.77e-05	7.6e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.77e-05	0.000104	CbGpPWpGaD
Isotretinoin—Hypotension—Doxorubicin—prostate cancer	1.76e-05	7.56e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ERCC2—prostate cancer	1.76e-05	0.000104	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—VDR—prostate cancer	1.76e-05	0.000104	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Epirubicin—prostate cancer	1.75e-05	7.54e-05	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—prostate cancer	1.75e-05	7.53e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—SIRT1—prostate cancer	1.75e-05	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.74e-05	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACSL4—prostate cancer	1.74e-05	0.000103	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSD17B3—prostate cancer	1.74e-05	0.000103	CbGpPWpGaD
Isotretinoin—Pain—Epirubicin—prostate cancer	1.74e-05	7.47e-05	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—prostate cancer	1.74e-05	7.47e-05	CcSEcCtD
Isotretinoin—Nausea—Capecitabine—prostate cancer	1.73e-05	7.45e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—NR3C1—prostate cancer	1.73e-05	0.000102	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.72e-05	0.000102	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—VDR—prostate cancer	1.72e-05	0.000102	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	1.72e-05	0.000102	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.72e-05	0.000102	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.72e-05	0.000102	CbGpPWpGaD
Isotretinoin—Dizziness—Prednisone—prostate cancer	1.72e-05	7.39e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.71e-05	7.37e-05	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—prostate cancer	1.7e-05	7.31e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—prostate cancer	1.69e-05	7.26e-05	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—prostate cancer	1.68e-05	7.21e-05	CcSEcCtD
Isotretinoin—RARA—Gene Expression—SIRT1—prostate cancer	1.67e-05	9.9e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SIRT1—prostate cancer	1.67e-05	9.9e-05	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Epirubicin—prostate cancer	1.67e-05	7.2e-05	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—prostate cancer	1.67e-05	7.19e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PHGDH—prostate cancer	1.67e-05	9.85e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ARG2—prostate cancer	1.67e-05	9.85e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—UMPS—prostate cancer	1.67e-05	9.85e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Epirubicin—prostate cancer	1.66e-05	7.15e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.66e-05	9.8e-05	CbGpPWpGaD
Isotretinoin—Dyspepsia—Doxorubicin—prostate cancer	1.66e-05	7.12e-05	CcSEcCtD
Isotretinoin—Vomiting—Prednisone—prostate cancer	1.65e-05	7.1e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—VDR—prostate cancer	1.65e-05	9.75e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—VDR—prostate cancer	1.65e-05	9.75e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.64e-05	9.69e-05	CbGpPWpGaD
Isotretinoin—Rash—Prednisone—prostate cancer	1.64e-05	7.04e-05	CcSEcCtD
Isotretinoin—Dermatitis—Prednisone—prostate cancer	1.64e-05	7.04e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—LDHB—prostate cancer	1.63e-05	9.66e-05	CbGpPWpGaD
Isotretinoin—Decreased appetite—Doxorubicin—prostate cancer	1.63e-05	7.03e-05	CcSEcCtD
Isotretinoin—Headache—Prednisone—prostate cancer	1.63e-05	7e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—DNMT3B—prostate cancer	1.62e-05	9.6e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.62e-05	6.98e-05	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—prostate cancer	1.62e-05	6.97e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PPARA—prostate cancer	1.62e-05	9.57e-05	CbGpPWpGaD
Isotretinoin—Urticaria—Epirubicin—prostate cancer	1.61e-05	6.94e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NR3C1—prostate cancer	1.61e-05	9.5e-05	CbGpPWpGaD
Isotretinoin—Pain—Doxorubicin—prostate cancer	1.61e-05	6.91e-05	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—prostate cancer	1.61e-05	6.91e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—prostate cancer	1.61e-05	6.91e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—prostate cancer	1.61e-05	6.91e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—LPL—prostate cancer	1.61e-05	9.49e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ERCC2—prostate cancer	1.61e-05	9.49e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP3A5—prostate cancer	1.6e-05	9.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.6e-05	9.43e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPL10—prostate cancer	1.59e-05	9.41e-05	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—prostate cancer	1.58e-05	9.36e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR3C1—prostate cancer	1.58e-05	9.34e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ERCC2—prostate cancer	1.57e-05	9.3e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HIST1H2BG—prostate cancer	1.56e-05	9.24e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.55e-05	9.18e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ITGB3—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR3C1—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PDHA1—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TCN2—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA3—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—UCP3—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Doxorubicin—prostate cancer	1.55e-05	6.66e-05	CcSEcCtD
Isotretinoin—Nausea—Prednisone—prostate cancer	1.54e-05	6.64e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.54e-05	6.61e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HIST1H4H—prostate cancer	1.51e-05	8.92e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NPPA—prostate cancer	1.51e-05	8.92e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ERCC2—prostate cancer	1.51e-05	8.92e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ERCC2—prostate cancer	1.51e-05	8.92e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PPARA—prostate cancer	1.51e-05	8.9e-05	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—prostate cancer	1.5e-05	6.44e-05	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—prostate cancer	1.49e-05	6.42e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—prostate cancer	1.49e-05	6.39e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—prostate cancer	1.49e-05	6.39e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NR3C1—prostate cancer	1.49e-05	8.78e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR3C1—prostate cancer	1.49e-05	8.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MED12—prostate cancer	1.49e-05	8.78e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PPARA—prostate cancer	1.48e-05	8.75e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSD3B1—prostate cancer	1.48e-05	8.73e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC22A3—prostate cancer	1.48e-05	8.73e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ESR1—prostate cancer	1.47e-05	8.67e-05	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6—prostate cancer	1.46e-05	8.64e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Epirubicin—prostate cancer	1.46e-05	6.27e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—PPARA—prostate cancer	1.45e-05	8.58e-05	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—prostate cancer	1.45e-05	8.56e-05	CbGpPWpGaD
Isotretinoin—Pruritus—Epirubicin—prostate cancer	1.44e-05	6.18e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.43e-05	8.47e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.43e-05	8.45e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.43e-05	8.43e-05	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—prostate cancer	1.42e-05	8.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PPARA—prostate cancer	1.42e-05	8.38e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA4—prostate cancer	1.42e-05	8.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TBXAS1—prostate cancer	1.42e-05	8.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.4e-05	8.26e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PPARA—prostate cancer	1.39e-05	8.23e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PPARA—prostate cancer	1.39e-05	8.23e-05	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—prostate cancer	1.39e-05	5.98e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—prostate cancer	1.39e-05	5.96e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.39e-05	8.18e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA2—prostate cancer	1.38e-05	8.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—prostate cancer	1.37e-05	8.07e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SULT1A1—prostate cancer	1.36e-05	8.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCG5—prostate cancer	1.36e-05	8.06e-05	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—prostate cancer	1.36e-05	8.05e-05	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—prostate cancer	1.36e-05	8.05e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—prostate cancer	1.35e-05	5.8e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—LEP—prostate cancer	1.35e-05	7.95e-05	CbGpPWpGaD
Isotretinoin—Dizziness—Epirubicin—prostate cancer	1.34e-05	5.78e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR1—prostate cancer	1.34e-05	7.93e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA1—prostate cancer	1.33e-05	7.87e-05	CbGpPWpGaD
Isotretinoin—Pruritus—Doxorubicin—prostate cancer	1.33e-05	5.72e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.32e-05	7.81e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KDR—prostate cancer	1.32e-05	7.79e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NAT2—prostate cancer	1.32e-05	7.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTO1—prostate cancer	1.32e-05	7.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSD3B2—prostate cancer	1.32e-05	7.78e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR1—prostate cancer	1.32e-05	7.77e-05	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—prostate cancer	1.29e-05	5.56e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—prostate cancer	1.29e-05	5.53e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—CREBBP—prostate cancer	1.29e-05	7.6e-05	CbGpPWpGaD
Isotretinoin—Rash—Epirubicin—prostate cancer	1.28e-05	5.51e-05	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—prostate cancer	1.28e-05	5.5e-05	CcSEcCtD
Isotretinoin—Headache—Epirubicin—prostate cancer	1.27e-05	5.47e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.27e-05	7.49e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPS19—prostate cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLCB2—prostate cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—LRP2—prostate cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2C18—prostate cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR1—prostate cancer	1.26e-05	7.45e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR1—prostate cancer	1.26e-05	7.45e-05	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—prostate cancer	1.24e-05	5.35e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—P4HB—prostate cancer	1.24e-05	7.32e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.21e-05	7.17e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—DNMT1—prostate cancer	1.21e-05	7.13e-05	CbGpPWpGaD
Isotretinoin—Nausea—Epirubicin—prostate cancer	1.21e-05	5.19e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—SERPINE1—prostate cancer	1.21e-05	7.12e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC22A1—prostate cancer	1.2e-05	7.12e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—PPARA—prostate cancer	1.2e-05	7.12e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—CREBBP—prostate cancer	1.2e-05	7.07e-05	CbGpPWpGaD
Isotretinoin—Vomiting—Doxorubicin—prostate cancer	1.2e-05	5.14e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.19e-05	7.04e-05	CbGpPWpGaD
Isotretinoin—Rash—Doxorubicin—prostate cancer	1.19e-05	5.1e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NCOA2—prostate cancer	1.19e-05	7e-05	CbGpPWpGaD
Isotretinoin—Dermatitis—Doxorubicin—prostate cancer	1.18e-05	5.09e-05	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—prostate cancer	1.18e-05	5.07e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CREBBP—prostate cancer	1.18e-05	6.95e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SULT2A1—prostate cancer	1.17e-05	6.94e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.17e-05	6.94e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EZH2—prostate cancer	1.17e-05	6.91e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—GSK3B—prostate cancer	1.17e-05	6.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MED12—prostate cancer	1.16e-05	6.83e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—CREBBP—prostate cancer	1.15e-05	6.81e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—INS—prostate cancer	1.15e-05	6.79e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GNG5—prostate cancer	1.15e-05	6.77e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PARP1—prostate cancer	1.14e-05	6.76e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CREBBP—prostate cancer	1.13e-05	6.66e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—SERPINE1—prostate cancer	1.12e-05	6.63e-05	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—prostate cancer	1.12e-05	4.8e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—CREBBP—prostate cancer	1.11e-05	6.53e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CREBBP—prostate cancer	1.11e-05	6.53e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA3—prostate cancer	1.1e-05	6.52e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SERPINE1—prostate cancer	1.1e-05	6.52e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.08e-05	6.41e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR2—prostate cancer	1.08e-05	6.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HSPA1A—prostate cancer	1.08e-05	6.4e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SERPINE1—prostate cancer	1.08e-05	6.39e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP2—prostate cancer	1.08e-05	6.36e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAP2K1—prostate cancer	1.08e-05	6.35e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HPGDS—prostate cancer	1.05e-05	6.22e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2C19—prostate cancer	1.05e-05	6.18e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SERPINE1—prostate cancer	1.04e-05	6.13e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SERPINE1—prostate cancer	1.04e-05	6.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—FGF2—prostate cancer	1.02e-05	6.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTT1—prostate cancer	1.02e-05	6.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACHE—prostate cancer	1.02e-05	6.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2A6—prostate cancer	1.01e-05	5.97e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.01e-05	5.94e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOA1—prostate cancer	9.99e-06	5.9e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.91e-06	5.86e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKR1C3—prostate cancer	9.82e-06	5.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—JAK2—prostate cancer	9.8e-06	5.79e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PRKACB—prostate cancer	9.77e-06	5.77e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP17A1—prostate cancer	9.67e-06	5.71e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AR—prostate cancer	9.57e-06	5.66e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.56e-06	5.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.54e-06	5.64e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ERBB2—prostate cancer	9.43e-06	5.57e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA2—prostate cancer	9.21e-06	5.44e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC5A5—prostate cancer	8.79e-06	5.19e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SIRT1—prostate cancer	8.73e-06	5.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—VDR—prostate cancer	8.6e-06	5.08e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2E1—prostate cancer	8.59e-06	5.07e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NQO1—prostate cancer	8.49e-06	5.02e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TH—prostate cancer	8.37e-06	4.94e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.31e-06	4.91e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP3A4—prostate cancer	8.28e-06	4.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—prostate cancer	8.25e-06	4.88e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.24e-06	4.87e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1B1—prostate cancer	8.14e-06	4.81e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—prostate cancer	8.09e-06	4.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GGT1—prostate cancer	7.88e-06	4.66e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ERCC2—prostate cancer	7.87e-06	4.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA1—prostate cancer	7.76e-06	4.59e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR3C1—prostate cancer	7.74e-06	4.58e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EP300—prostate cancer	7.67e-06	4.53e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—prostate cancer	7.65e-06	4.52e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—prostate cancer	7.63e-06	4.51e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SRC—prostate cancer	7.46e-06	4.41e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—prostate cancer	7.27e-06	4.29e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPARA—prostate cancer	7.26e-06	4.29e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—STAT3—prostate cancer	7.19e-06	4.25e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.18e-06	4.24e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—COMT—prostate cancer	7.11e-06	4.2e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—prostate cancer	7.1e-06	4.2e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—prostate cancer	7.08e-06	4.18e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—prostate cancer	6.98e-06	4.12e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ITPR1—prostate cancer	6.97e-06	4.12e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.85e-06	4.05e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—prostate cancer	6.84e-06	4.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TGFB1—prostate cancer	6.67e-06	3.94e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—prostate cancer	6.58e-06	3.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR1—prostate cancer	6.57e-06	3.88e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—prostate cancer	6.56e-06	3.88e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—prostate cancer	6.56e-06	3.88e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—prostate cancer	6.54e-06	3.86e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—prostate cancer	6.51e-06	3.84e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—LPL—prostate cancer	6.39e-06	3.77e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—prostate cancer	6.18e-06	3.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A1—prostate cancer	6.17e-06	3.64e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ERCC2—prostate cancer	6.12e-06	3.61e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CREBBP—prostate cancer	5.76e-06	3.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—prostate cancer	5.75e-06	3.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPARA—prostate cancer	5.64e-06	3.33e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SERPINE1—prostate cancer	5.4e-06	3.19e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CAV1—prostate cancer	5.3e-06	3.13e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—prostate cancer	5.29e-06	3.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.07e-06	2.99e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—prostate cancer	5.02e-06	2.97e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—prostate cancer	4.84e-06	2.86e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CG—prostate cancer	4.83e-06	2.85e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—prostate cancer	4.75e-06	2.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—prostate cancer	4.64e-06	2.74e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—INS—prostate cancer	4.57e-06	2.7e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—prostate cancer	4.55e-06	2.69e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—prostate cancer	4.55e-06	2.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CREBBP—prostate cancer	4.48e-06	2.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CD—prostate cancer	4.25e-06	2.51e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NOS3—prostate cancer	4.01e-06	2.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CB—prostate cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—prostate cancer	3.67e-06	2.17e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—prostate cancer	3.42e-06	2.02e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—prostate cancer	3.2e-06	1.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—prostate cancer	3.05e-06	1.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—prostate cancer	2.37e-06	1.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—prostate cancer	2.26e-06	1.33e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—prostate cancer	1.84e-06	1.09e-05	CbGpPWpGaD
